P
SWAV

Pitcairn’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Pitcairn’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,037
Closed -$206K – 702
2023
Q3 		$206K Sell
1,037
-104
-9% -$24.6K 0.02% 597
2023
Q2 		$326K Sell
1,141
-1,146
-50% -$318K 0.03% 488
2023
Q1 		$496K Buy
2,287
+291
+15% +$56.7K 0.05% 340
2022
Q4 		$410K Sell
1,996
-28
-1% -$7.08K 0.04% 361
2022
Q3 		$563K Sell
2,024
-217
-10% -$55.2K 0.06% 265
2022
Q2 		$428K Buy
2,241
+158
+8% +$27.9K 0.05% 339
2022
Q1 		$432K Sell
2,083
-274
-12% -$45.2K 0.04% 403
2021
Q4 		$420K Buy
+2,357
New +$465K 0.03% 419

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pitcairn's SWAV Position: Q4 2023 in Review

Pitcairn sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 1,037 shares — an estimated $206K sold.

Pitcairn first reported a position in SWAV in Q4 2021 and held it in 8 quarters. The position peaked at $563K in Q3 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Pitcairn reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Pitcairn sold 1,037 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $206K.
  • Pitcairn first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Pitcairn's Shockwave Medical, Inc. Common Stock position peaked at $563K in Q3 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Pitcairn's 13F filing for Q4 2023, filed 14 Feb 2024.